The convergence of life sciences and technology continues to have a tremendous impact across the life sciences industry. Innovation is moving at a rapid pace, investment across the sector is at an all-time high, and companies are adopting new business models in response to the ongoing pandemic.
Morrison & Foerster welcomed 100+ attendees for our virtual Life Sciences MoForum to discuss the business, legal, and regulatory trends that are driving innovation and growth in the life sciences today.
We hosted a series of three programs featuring leading life sciences innovators to discuss the key strategies shaping the industry today and what to expect in 2022. We concluded with a fireside chat with Shannon Klinger, chief legal officer of Moderna, who shared her unique perspective on the industry’s response to the pandemic and her outlook for the future.
Tuesday, January 25, 2022 Digital Transformation in the Life Sciences
Moderated by: Brigid Bondoc, of counsel, FDA Regulatory and Compliance practice
Melinda Decker, Digital Health Advisor and former Chief Commercial Officer, Mymee
Chris Bergstrom, President, Amalgam Rx
Laura Taraboanta, Sr. Manager, Head of Clinical Innovations, Click Therapeutics
Shaheen Lakhan, Chief Medical Officer, Click Therapeutics
Wednesday, January 26, 2022 The Future of Drug Discovery and Diagnostics
Moderated by: Matthew Karlyn, partner, Life Sciences Transactions & Licensing practice
Scott Carter, Assistant General Counsel, BeiGene
Michelle Egger, Co-Founder & CEO, BIOMILQ
Daniel Oliver, Co-Founder & CEO, Rejuvenate Bio
William W. Li, M.D., President and Medical Director, The Angiogenesis Foundation
Thursday, January 27, 2022 Fireside Chat with Shannon Klinger, Chief Legal Officer, Moderna
Moderated by: Deanne Maynard, partner and co-chair Appellate and Supreme Court practice